{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:44:40Z","timestamp":1794663880374,"version":"4.9.1"},"reference-count":59,"publisher":"IOP Publishing","issue":"4","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"crossref","award":["2022FI_B 00386"],"award-info":[{"award-number":["2022FI_B 00386"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council","award":["MR\/WR019086\/1"],"award-info":[{"award-number":["MR\/WR019086\/1"]}]},{"name":"Duchenne Parent Project Spain","award":["DPPE\/09_2020"],"award-info":[{"award-number":["DPPE\/09_2020"]}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biofabrication"],"published-print":{"date-parts":[[2023,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Duchenne muscular dystrophy (DMD) is the most prevalent neuromuscular disease diagnosed in childhood. It is a progressive and wasting disease, characterized by a degeneration of skeletal and cardiac muscles caused by the lack of dystrophin protein. The absence of this crucial structural protein leads to sarcolemmal fragility, resulting in muscle fiber damage during contraction. Despite ongoing efforts, there is no cure available for DMD patients. One of the primary challenges is the limited efficacy of current preclinical tools, which fail in modeling the biological complexity of the disease. Human-based three-dimensional (3D) cell culture methods appear as a novel approach to accelerate preclinical research by enhancing the reproduction of pathophysiological processes in skeletal muscle. In this work, we developed a patient-derived functional 3D skeletal muscle model of DMD that reproduces the sarcolemmal damage found in the native DMD muscle. These bioengineered skeletal muscle tissues exhibit contractile functionality, as they responded to electrical pulse stimulation. Sustained contractile regimes induced the loss of myotube integrity, mirroring the pathological myotube breakdown inherent in DMD due to sarcolemmal instability. Moreover, damaged DMD tissues showed disease functional phenotypes, such as tetanic fatigue. We also evaluated the therapeutic effect of utrophin upregulator drug candidates on the functionality of the skeletal muscle tissues, thus providing deeper insight into the real impact of these treatments. Overall, our findings underscore the potential of bioengineered 3D skeletal muscle technology to advance DMD research and facilitate the development of novel therapies for DMD and related neuromuscular disorders.<\/jats:p>","DOI":"10.1088\/1758-5090\/acfb3d","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T18:49:59Z","timestamp":1695149399000},"page":"045024","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Mimicking sarcolemmal damage in vitro: a contractile 3D model of skeletal muscle for drug testing in Duchenne muscular dystrophy"],"prefix":"10.1088","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-073X","authenticated-orcid":true,"given":"Ainoa","family":"Tejedera-Villafranca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisol","family":"Montolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3636-8013","authenticated-orcid":true,"given":"Javier","family":"Ram\u00f3n-Azc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1854-6082","authenticated-orcid":true,"given":"Juan M","family":"Fern\u00e1ndez-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"266","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"bfacfb3dbib1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"bfacfb3dbib2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum. Mutat."},{"key":"bfacfb3dbib3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"bfacfb3dbib4","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/cphy.c140048","article-title":"The dystrophin complex: structure, function and implications for therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr. Physiol."},{"key":"bfacfb3dbib5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.physiol.010908.163216","article-title":"Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies","volume":"71","author":"Wallace","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"bfacfb3dbib6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1023\/A:1006812004945","article-title":"The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy","volume":"179","author":"Petrof","year":"1998","journal-title":"Mol. Cell. Biochem."},{"key":"bfacfb3dbib7","doi-asserted-by":"publisher","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated pathology in Duchenne muscular dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"bfacfb3dbib8","first-page":"121","article-title":"Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients","volume":"31","author":"Passamano","year":"2012","journal-title":"Acta Myol."},{"key":"bfacfb3dbib9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/d41573-019-00074-z","article-title":"Trends in clinical success rates and therapeutic focus","volume":"18","author":"Dowden","year":"2019","journal-title":"Nat. Rev. Drug Discovery"},{"key":"bfacfb3dbib10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107719","article-title":"Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy","volume":"220","author":"Iftikhar","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"bfacfb3dbib11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11940-018-0513-6","article-title":"Current and emerging therapies for Duchenne muscular dystrophy","volume":"20","author":"Crone","year":"2018","journal-title":"Curr. Treat. Options Neurol."},{"key":"bfacfb3dbib12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/jcm10040820","article-title":"Innovative therapeutic approaches for Duchenne muscular dystrophy","volume":"10","author":"Fortunato","year":"2021","journal-title":"J. Clin. Med."},{"key":"bfacfb3dbib13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2044-5040-1-8","article-title":"Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy","volume":"1","author":"Goyenvalle","year":"2011","journal-title":"Skelet Muscle"},{"key":"bfacfb3dbib14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/hum.2023.026","article-title":"The future of exon skipping for Duchenne muscular dystrophy","volume":"34","author":"Aartsma-Rus","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"bfacfb3dbib15","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1038\/mtna.2014.6","article-title":"What can we learn from clinical trials of exon skipping for DMD?","volume":"3","author":"Lu","year":"2014","journal-title":"Mol. Ther."},{"key":"bfacfb3dbib16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.nmd.2021.08.004","article-title":"The DMD gene and therapeutic approaches to restore dystrophin","volume":"31","author":"Fortunato","year":"2021","journal-title":"Neuromuscul. Disorders"},{"key":"bfacfb3dbib17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/d41586-023-01799-z","article-title":"\u2018It\u2019s a vote for hope\u2019: first gene therapy for muscular dystrophy nears approval, but will it work?","volume":"618","author":"Reardon","year":"2023","journal-title":"Nature"},{"key":"bfacfb3dbib18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/nan.12735","article-title":"Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies","volume":"47","author":"Soblechero-Mart\u00edn","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"bfacfb3dbib19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s0306-3623(97)00307-8","article-title":"Halofuginone: a novel antifibrotic therapy","volume":"30","author":"Pines","year":"1998","journal-title":"Gen. Pharmacol. Vascular Syst."},{"key":"bfacfb3dbib20","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.3390\/ijms22137063","article-title":"Differential effects of halofuginone enantiomers on muscle fibrosis and histopathology in Duchenne muscular dystrophy","volume":"22","author":"Mordechay","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"bfacfb3dbib21","doi-asserted-by":"publisher","first-page":"23249","DOI":"10.18632\/oncotarget.4021","article-title":"Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy","volume":"6","author":"Levi","year":"2015","journal-title":"Oncotarget"},{"key":"bfacfb3dbib22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5114\/aoms.2016.63743","article-title":"2D and 3D cell cultures\u2014a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"bfacfb3dbib23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijsu.2019.10.015","article-title":"The current state of animal models in research: a review","volume":"72","author":"Robinson","year":"2019","journal-title":"Int. J. Surg."},{"key":"bfacfb3dbib24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nhtm.2014.08.001","article-title":"Animal models in translational medicine: validation and prediction","volume":"2","author":"Denayer","year":"2014","journal-title":"New Horiz. Transl. Med."},{"key":"bfacfb3dbib25","doi-asserted-by":"publisher","DOI":"10.1177\/2041731420981339","article-title":"Bioengineered in vitro skeletal muscles as new tools for muscular dystrophies preclinical studies","volume":"12","author":"Fern\u00e1ndez-Costa","year":"2021","journal-title":"J. Tissue Eng."},{"key":"bfacfb3dbib26","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700506","article-title":"Organ-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies","volume":"7","author":"Ahadian","year":"2018","journal-title":"Adv. Healthcare Mater."},{"key":"bfacfb3dbib27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.04885","article-title":"Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs","volume":"4","author":"Madden","year":"2015","journal-title":"eLife"},{"key":"bfacfb3dbib28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.77204","article-title":"Contractile force assessment methods for in vitro skeletal muscle tissues","volume":"11","author":"Vesga-Castro","year":"2022","journal-title":"eLife"},{"key":"bfacfb3dbib29","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112966","article-title":"Innovation in culture systems to study muscle complexity","volume":"411","author":"Moyle","year":"2022","journal-title":"Exp. Cell Res."},{"key":"bfacfb3dbib30","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/cells9081780","article-title":"Derivation and characterization of immortalized human muscle satellite cell clones from muscular dystrophy patients and healthy individuals","volume":"9","author":"Massenet","year":"2020","journal-title":"Cells"},{"key":"bfacfb3dbib31","doi-asserted-by":"publisher","DOI":"10.1002\/admt.202200873","article-title":"Training-on-a-chip: a multi-organ device to study the effect of muscle exercise on insulin secretion in vitro","volume":"8","author":"Fern\u00e1ndez-Costa","year":"2022","journal-title":"Adv. Mater. Technol."},{"key":"bfacfb3dbib32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"bfacfb3dbib33","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"bfacfb3dbib34","doi-asserted-by":"publisher","DOI":"10.1002\/admt.201800631","article-title":"Force modulation and adaptability of 3D-bioprinted biological actuators based on skeletal muscle tissue","volume":"4","author":"Mestre","year":"2019","journal-title":"Adv. Mater. Technol."},{"key":"bfacfb3dbib35","doi-asserted-by":"publisher","first-page":"e2519","DOI":"10.21769\/BioProtoc.2519","article-title":"Quantification of membrane damage\/cell death using Evan\u2019s blue staining technique","volume":"7","author":"Vijayaraghavareddy","year":"2017","journal-title":"Bio-protocol"},{"key":"bfacfb3dbib36","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","article-title":"Cellpose 2.0: how to train your own model","volume":"19","author":"Pachitariu","year":"2022","journal-title":"Nat. Methods"},{"key":"bfacfb3dbib37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91191-6","article-title":"Automatic and unbiased segmentation and quantification of myofibers in skeletal muscle","volume":"11","author":"Waisman","year":"2021","journal-title":"Sci. Rep."},{"key":"bfacfb3dbib38","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7628037","article-title":"Evans blue dye: a revisit of its applications in biomedicine","volume":"2018","author":"Yao","year":"2018","journal-title":"Contrast Media Mol. Imaging"},{"key":"bfacfb3dbib39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.0021-8782.2001.00008.x","article-title":"Evans blue dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability","volume":"200","author":"Hamer","year":"2002","journal-title":"J. Anat."},{"key":"bfacfb3dbib40","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1021\/jm200135z","article-title":"Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy","volume":"54","author":"Chancellor","year":"2011","journal-title":"J. Med. Chem."},{"key":"bfacfb3dbib41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bpj.2020.05.037","article-title":"Effect of DMSO on the mechanical and structural properties of model and biological membranes","volume":"119","author":"Gironi","year":"2020","journal-title":"Biophys. J."},{"key":"bfacfb3dbib42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/09687688.2012.687460","article-title":"Ion transport through dimethyl sulfoxide (DMSO) induced transient water pores in cell membranes","volume":"29","author":"He","year":"2012","journal-title":"Mol. Membr. Biol."},{"key":"bfacfb3dbib43","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419833478","article-title":"Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies","volume":"12","author":"Piga","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"bfacfb3dbib44","doi-asserted-by":"publisher","first-page":"C409","DOI":"10.1152\/ajpcell.00212.2021","article-title":"Murine models of Duchenne muscular dystrophy: is there a best model?","volume":"321","author":"Swiderski","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"bfacfb3dbib45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1242\/dmm.018424","article-title":"Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy","volume":"8","author":"McGreevy","year":"2015","journal-title":"Dis. Models Mech."},{"key":"bfacfb3dbib46","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/nbm.3593","article-title":"Post-contractile BOLD contrast in skeletal muscle at 7 T reveals inter-individual heterogeneity in the physiological responses to muscle contraction","volume":"29","author":"Towse","year":"2016","journal-title":"NMR Biomed."},{"key":"bfacfb3dbib47","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1113\/JP284442","article-title":"Can muscle typology explain the inter-individual variability in resistance training adaptations?","volume":"601","author":"van Vossel","year":"2023","journal-title":"J. Physiol."},{"key":"bfacfb3dbib48","doi-asserted-by":"publisher","first-page":"e4347","DOI":"10.1371\/journal.pone.0004347","article-title":"Clinical heterogeneity of Duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up","volume":"4","author":"Desguerre","year":"2009","journal-title":"PLoS One"},{"key":"bfacfb3dbib49","doi-asserted-by":"publisher","first-page":"C230","DOI":"10.1152\/ajpcell.00199.2003","article-title":"Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury","volume":"286","author":"Lovering","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"bfacfb3dbib50","doi-asserted-by":"publisher","first-page":"C1290","DOI":"10.1152\/ajpcell.2000.279.4.C1290","article-title":"Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice","volume":"279","author":"Lynch","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"bfacfb3dbib51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/ijms24010362","article-title":"Mechanisms of myofibre death in muscular dystrophies: the emergence of the regulated forms of necrosis in myology","volume":"24","author":"Bencze","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"bfacfb3dbib52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1083\/jcb.201603111","article-title":"A human in vitro model of Duchenne muscular dystrophy muscle formation and contractility","volume":"215","author":"Nesmith","year":"2016","journal-title":"J. Cell Biol."},{"key":"bfacfb3dbib53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.actbio.2021.05.020","article-title":"De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle","volume":"132","author":"Ebrahimi","year":"2021","journal-title":"Acta Biomater."},{"key":"bfacfb3dbib54","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","article-title":"Three-dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering","volume":"23","author":"Maffioletti","year":"2018","journal-title":"Cell Rep."},{"key":"bfacfb3dbib55","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1002\/jcsm.13094","article-title":"Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy","volume":"13","author":"Shahriyari","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"bfacfb3dbib56","doi-asserted-by":"publisher","DOI":"10.1177\/20417314221122127","article-title":"High-throughput, real-time monitoring of engineered skeletal muscle function using magnetic sensing","volume":"13","author":"Smith","year":"2022","journal-title":"J. Tissue Eng."},{"key":"bfacfb3dbib57","doi-asserted-by":"publisher","DOI":"10.1177\/20417314221119628","article-title":"Full-length dystrophin deficiency leads to contractile and calcium transient defects in human engineered heart tissues","volume":"13","author":"Bremner","year":"2022","journal-title":"J. Tissue Eng."},{"key":"bfacfb3dbib58","doi-asserted-by":"publisher","first-page":"C749","DOI":"10.1152\/ajpcell.00049.2021","article-title":"Electrophysiological analysis of healthy and dystrophic 3D bioengineered skeletal muscle tissues","volume":"321","author":"Nguyen","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"bfacfb3dbib59","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.050107","article-title":"Muscle-on-a-chip devices: a new era for in vitro modelling of muscular dystrophies","volume":"16","author":"Fern\u00e1ndez-Costa","year":"2023","journal-title":"Dis. Models Mech."}],"container-title":["Biofabrication"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/acfb3d","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/acfb3d\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/acfb3d","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/acfb3d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/acfb3d\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/acfb3d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/acfb3d\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/acfb3d\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T04:04:17Z","timestamp":1695787457000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/acfb3d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,9,27]]},"published-print":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1758-5090\/acfb3d","relation":{},"ISSN":["1758-5082","1758-5090"],"issn-type":[{"value":"1758-5082","type":"print"},{"value":"1758-5090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"Mimicking sarcolemmal damage in vitro: a contractile 3D model of skeletal muscle for drug testing in Duchenne muscular dystrophy","name":"article_title","label":"Article Title"},{"value":"Biofabrication","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2023 The Author(s). Published by IOP Publishing Ltd","name":"copyright_information","label":"Copyright Information"},{"value":"2023-06-22","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2023-09-19","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2023-09-27","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}